Michael J Fox Foundation raises $1m on #GivingTuesday

News

Author: Parkinson's Life editorsPublished: 7 December 2017

Prep: Cook: Serves:

The Michael J Fox Foundation for Parkinson’s Research raised $1 million on #GivingTuesday – 28 November – as part of their #1Day1million fundraising campaign.

The charity had pledged to match-fund any donation up to the one million dollar mark, with 89 cents from every dollar spent at The Foundation going directly to research programmes.

In a statement, the organisation said: “We did it: thanks to your support and energy, we met our Giving Tuesday goal of raising $1 million in one day, to help speed a cure for Parkinson’s disease.

“Thousands of friends and followers shared their dedication to fuelling Parkinson’s research, championed our mission online, and most critically, donated. It was incredible to see the outpouring of support for the Parkinson’s community, demonstrating how together, we can – and we will – cure Parkinson’s disease.”

Last Month

Next Month

Go Back

Share this story

Comments

Advances

Global Parkinson’s study reveals sleep as biggest influence on wellbeing

First insights revealed from data gathered by smartphones

Poem for World Parkinson’s Day: “Parkinson’s can be a state of mind, rather than an illness”

Daily Parkinson’s poet pens new piece for World Parkinson’s Day

The challenges and joys of writing with Parkinson’s

Ireland-based author Kathleen Reardon shares how she’s adapted to keep do

New biotech to drive forward GDNF treatment for Parkinson’s disease

UK charity Parkinson’s UK is creating a new company, Vivifi Biotech, to develop a treatment with potential to stop or reverse Parkinson’s disease. The experimental therapy surgically distributes GDNF, a protein that is naturally produced by the brain to protect cells, directly into the brain. The charity previously funded a clinical trial to investigate whether boosting GDNF levels could regenerate dying brain cells in people with Parkinson’s. Over the next two years, it will invest up to £800,000 to prepare for a second trial. Arthur Roach, head of research at Parkinson’s UK, said: “While our initial trial didn’t meet its critical endpoint, it did reveal robust evidence indicating that GDNF can possibly reverse Parkinson’s. This is why Parkinson’s UK is committed to continuing research into this potential treatment.” Vivifi Biotech, Roach added, will “bring the right people together to plan a new trial that meets the needs of patients, regulatory…

New wearable medical device for Parkinson’s disease to launch this year

The Imperial College London Innovation Fund, UK, has invested £205,000 to support UK-based tech company Charco Neurotech in its development of a non-invasive medical device for people with Parkinson’s disease. CUE1, a circular device that attaches to the sternum with medical adhesives, uses specialised vibration to help alleviate physical symptoms of Parkinson’s disease. Initial user testing among people with the condition found that the device improved movement by an average of 16%, with testers reporting benefits for walking and fine motor tasks. Lucy Jung, CEO and co-founder of Charco Neurotech, said: “We believe that CUE1 has the potential to significantly improve [Parkinson’s disease] symptoms through its unique controlled vibration technology. We are excited to continue our work on the device and we look forward to the outcome of our proposed clinical trials.” Charco Neurotech will use the Imperial College investment to initiate a clinical trial and fund the device’s manufacture for…

New study brings scientists a “vital step” closer to understanding Parkinson’s disease

A new study from scientists at the University of Cambridge, UK, has brought researchers “a vital step” closer to discovering the origins of Parkinson’s disease. The research, published in the scientific journal ‘Nature Communications’, offered insights on the protein alpha-synuclein, which clumps together in the neurons of people with Parkinson’s. The study focused on how the protein functions in those without the condition and revealed that it sticks to the inner side of the plasma membrane of nerve cells, but not the outer membrane – an insight that could help in the search for a cure. Lead study author, Dr Giuliana Fusco, said: “This study could unlock more information about this debilitating neurodegenerative disorder that can leave people unable to walk and talk. If we want to cure Parkinson’s, first we need to understand the function of alpha-synuclein, a protein present in everyone’s brains.”

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Phone
This field is for validation purposes and should be left unchanged.

Michael J Fox Foundation raises $1m on #GivingTuesday

News

Author: Parkinson's Life editorsPublished: 7 December 2017

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Advances

Global Parkinson’s study reveals sleep as biggest influence on wellbeing

Perspectives

Poem for World Parkinson’s Day: “Parkinson’s can be a state of mind, rather than an illness”

Interviews

The challenges and joys of writing with Parkinson’s

New biotech to drive forward GDNF treatment for Parkinson’s disease

New wearable medical device for Parkinson’s disease to launch this year

New study brings scientists a “vital step” closer to understanding Parkinson’s disease

{title}

Subscribe

Michael J Fox Foundation raises $1m on #GivingTuesday

News

Author: Parkinson's Life editorsPublished: 7 December 2017

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Advances

Global Parkinson’s study reveals sleep as biggest influence on wellbeing

Perspectives

Poem for World Parkinson’s Day: “Parkinson’s can be a state of mind, rather than an illness”

Interviews

The challenges and joys of writing with Parkinson’s

New biotech to drive forward GDNF treatment for Parkinson’s disease

New wearable medical device for Parkinson’s disease to launch this year

New study brings scientists a “vital step” closer to understanding Parkinson’s disease

{title}

Subscribe

Sign in